Cleveland Clinic, the University of Minnesota and University of Cambridge receive $1M grant to develop point-of-care biosensor for early detection and treatment personalization
ctDNA should be incorporated into care to help stratify risk pre-operatively and for post-operative surveillance
Screening assay effective across all stages, can identify tissue of origin
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement